MARKET

NERV

NERV

Minerva Neurosci
NASDAQ
2.404
-0.036
-1.48%
After Hours: 2.470 +0.066 +2.76% 19:55 05/29 EDT
OPEN
2.410
PREV CLOSE
2.440
HIGH
2.490
LOW
2.375
VOLUME
4.24K
TURNOVER
0
52 WEEK HIGH
13.49
52 WEEK LOW
2.286
MARKET CAP
16.81M
P/E (TTM)
-0.5367
1D
5D
1M
3M
1Y
5Y
Corcept (CORT) Rises as Cushing's Syndrome Study Meets Goal
NASDAQ · 15h ago
Mirum's (MIRM) Livmarli Aids Sales but Overdependence Concerns
NASDAQ · 1d ago
Weekly Report: what happened at NERV last week (0520-0524)?
Weekly Report · 2d ago
Candel (CADL) Reports Upbeat Data From Lung Cancer Study
NASDAQ · 5d ago
Cartesian (RNAC) Up as FDA Grants RMAT Tag to Descartes-08
NASDAQ · 6d ago
Esperion's (ESPR) Drugs Get EU Nod for Lowering Heart Risk
NASDAQ · 6d ago
Weekly Report: what happened at NERV last week (0513-0517)?
Weekly Report · 05/20 11:41
Weekly Report: what happened at NERV last week (0506-0510)?
Weekly Report · 05/13 11:55
More
About NERV
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company, which focused on the development and commercialization of product candidates to treat patients suffering from central nervous system (CNS) diseases. It is engaged in developing roluperidone for the treatment of negative symptoms in patients with schizophrenia and have exclusive rights to develop and commercialize MIN-301 for the treatment of Parkinson's disease. It has also co-developed seltorexant for the treatment of insomnia disorder and adjunctive treatment of the major depressive disorder (MDD). Roluperidone is a compound that blocks serotonin, sigma, and a-adrenergic receptors that are involved in the regulation of mood, cognition, sleep, and anxiety. Roluperidone has been designed to block a specific subtype of serotonin receptor called 5-HT2A. MIN-301 is a soluble recombinant form of the Neuregulin-1b1 (NRG-1b1), protein, for the treatment of Parkinson's disease and for other neurodegenerative disorders.

Webull offers Minerva Neurosciences Inc stock information, including NASDAQ: NERV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NERV stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NERV stock methods without spending real money on the virtual paper trading platform.